Emma Andrus, Associate Editor

The data was presented at the European Society of Contact Dermatitis in Dresden, Germany, this week.

The study, published in Dermato, showed that 92% of NMSC tumors showed measurable changes in depth of invasion from one image to the next.

The PD-1/IL-2α bispecific antibody fusion protein is intended for patients with unresectable locally advanced or metastatic melanoma.

The study showed significant improvement in repigmentation with silymarin, with patients of different sexes benefiting equally, though monthly differences were not significant.

The 83-year-old patient was being treated for mycosis fungoides.

42 studies with 1027 cases evaluated drugs like bimatoprost and apremilast for vitiligo.

Dermatology Times asked our readers to share what conferences they are looking forward to in the third quarter of 2024.

Keep up with the latest headlines in dermatology from the past week, including new research into AI versus clinician detection of skin cancer, parasitic worms in wound healing, and more.

Dermatology Times is looking back on the top stories in dermatology from the month of August.

Dermatology Times is recapping our top expert interviews from the month of August.

Researchers observed significant improvements in roughness and redness in patients treated with the non-cross-linked compound.

At T0, skin layers appeared normal, and at T1, filler deposits were clearly visible as hyporeflective areas.

One hundred patients with AK rated their therapies with the TSQM and Likert scale, and shared their treatment needs regarding goals, cost, type, duration, and location.

Researchers say further studies are needed to understand the effects of photoactivation, if any, in combination with PRP.

Bullous pemphigoid in youth is rare and can be missed due to negative BP180 ELISA results, complicating timely diagnosis in children.

Approximately 8.8% of patients achieved complete response a year after onset of diphenylcyclopropenone therapy.

Researchers tailored screening and surveillance schedules to individual risk of patients.

Rates of infection did not correlate with disease severity, however.

Keep up with the latest headlines in dermatology from the past week, including the presence of toxic "forever chemicals" in artificial turf, commercial availability of apremilast in the US, and more.

A comprehensive analysis of 71 studies revealed the highest lesion clearance and recurrence rates among individuals who had undergone surgery.

After treatment with the topical JAK inhibitor, researchers reported significant improvement of lesional skin.

In a review, researchers reported that ethnicity plays a role in outcomes, presentations, and more for individuals with systemic sclerosis.

Over 6 weeks, most saw patients saw improvement, with daily medication linked to better quality of life and reduced skin picking.

Researchers say promising study findings warrant further exploration of EID's potential on a larger scale.

At the correct dosage, researchers noted non-significant changes in BMI or metabolic syndrome markers among patients.

Patients with AD and psoriasis both report diminished levels of happiness compared to the general population.

Researchers assessed patterns of referral from a primary dermatological clinic in Japan.

Qing Yu Christina Weng, MD, shares insights into the drug's advancement following preliminary phase 1 findings.

Keep up with the latest headlines in dermatology from the past week, including honoring the teenage inventor of a soap to treat skin cancer, the US FDA's approval of nemolizumab for prurigo nodularis, and more.

Mendelian randomization suggested a potential causal relationship between the 2 variables.